The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Indivina 1 mg/5 mg tablets

Orion CorporationPA1327/005/002

Main Information

Trade NameIndivina 1 mg/5 mg tablets
Active SubstancesEstradiol valerate
Medroxyprogesterone acetate
Dosage FormTablet
Licence HolderOrion Corporation
Licence NumberPA1327/005/002

Group Information

ATC CodeG03FA Progestogens and estrogens, fixed combinations
G03FA12 medroxyprogesterone and estrogen


License statusAuthorised
Licence Issued21/07/2000
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back